Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday.
Soraya Ali reports.
[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results..
Moderna COVID-19 Vaccine Is 94.5% Effective, Company Reports.
The company released the data, which was
confirmed by..
A COVID-19 vaccine from Pfizer is supposedly 9% effective, and it was partially tested at Cincinnati Children's Hospital.
